You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
希瑪眼科(03309.HK)中期實現純利1371.2萬港元
格隆匯 08-31 17:20

格隆匯8月31日丨希瑪眼科(03309.HK)發佈公吿,截至2021年6月30日止6個月,實現收益5.21億港元,同比增長99.2%;毛利1.79億港元,同比增長191.0%;公司權益持有人應占期內利潤1371.2萬港元,上年同期虧損2098.1萬港元;基本每股盈利1.19港仙。

報吿期內,總收益同比大幅增長99.2%。除視力輔助產品銷售增加73.9%外,增長主要來自於提供眼科服務產生的收益增加至4.359億港元,增幅為91.3%,主要由於進行的手術數目及於中國香港及中國內地的眼科醫生及醫生人數增加所致。

儘管受到新型冠狀病毒疫情影響,集團於2021年上半年恢復增長勢頭,並繼續執行在粵港澳大灣區及中國內地其他地區擴充服務網絡的計劃。憑藉日益增長的服務網絡及優質的醫療服務聲譽,集團於中國香港及中國內地的收益分別增加88.2%及111.0%(以港元呈報)。

集團的第七間眼科醫院位於惠州,於2021年3月開始投入運作,佔地4000平方米,設有3間手術室及10間醫療室。集團位於廣州的第八間眼科醫院預計將於2021年底前開始營業。此外,集團正在東莞、佛山和揭陽設立三家眼科醫院,並在福建省福州設立一家眼科中心。全部預計將於未來6至9個月開始營業。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account